Skip to content

CellDiffuser: Multimodal Optical Time-Stretch Imaging Flow Cytometry and Diffusion Models for Lung Cancer Immunotherapy Diagnosis

Sep 2026 · ACS Photonics · Vol 13, pp. 5787-5796 · 0 citations · 34 references

TL;DR

This work establishes a cost-effective, high-throughput framework for single-cell phenotyping, offering a new paradigm to guide lung cancer personalized immunotherapy diagnosis.

Abstract

Immune checkpoint inhibitors have emerged as frontline therapies for lung cancer, yet the lack of reliable biomarkers for predicting the treatment response remains a critical challenge. While single-cell analysis offers a potent approach to probing physiological states, conventional techniques suffer from limited throughput and insufficient multimodal profiling capability. To address the aforementioned issues, we propose a novel framework for lung cancer immunotherapy diagnosis. Specifically, we develop multimodal optical time-stretch imaging flow cytometry (OTS-IFC) that simultaneously acquires label-free bright-field (BF) and quantitative phase (QP) images at a throughput of 10,000 cells/s. In response to the influence of phase unwrapping artifacts, we propose CellDiffuser, an intermediate domain transformation diffusion model that aligns BF and QP images in a shared latent space at a preselected time step, thus generating high-fidelity synthesized QP images. CellDiffuser achieves an SSIM of 0.747 in the leukocyte immunotherapy response prediction data set and an SSIM of 0.708 in the A549 cell death state identification data set. Finally, our framework demonstrates its practical utility in lung cancer immunotherapy diagnosis in the above two clinically relevant data sets. This work establishes a cost-effective, high-throughput framework for single-cell phenotyping, offering a new paradigm to guide lung cancer personalized immunotherapy diagnosis. The code is available at: https://github.com/yzygit1230/CellDiffuser.

View source

Similar papers

Review Open access Sep 2026

Recent Advances in Fluorescence Probes for Real-Time Imaging of Cancer Immunotherapy

Immunotherapy has emerged as a transformative paradigm in cancer treatment, significantly improving long-term patient survival rates. However, the relatively low immune response rate remains a primary obstacle to achieving precision oncology, necessitating the timely and accurate assessment of immunotherapy efficacy....

Ri-Tuan Huang, Hao-Tian Zhang, Rui Qu et al. · 0 citations
Review Sep 2026

Ultrasound Molecular Imaging and Visualization of Immune Biomarkers: A New Paradigm for Tumor Immunotherapy Response Assessment.

Cancer immunotherapy has revolutionized the treatment landscape, yet its clinical efficacy is limited by modest objective response rates and the emergence of atypical response patterns such as pseudoprogression and hyperprogression. Conventional RECIST criteria relying on anatomical size changes and invasive tissue bio...

Qiao-Ling Zhang, Shu-Fen Xiao, Jing-Xin He et al. · 0 citations
Open access Sep 2026

Microfluidic Light-Scattering Imaging Coupled with Deep Learning for Label-Free Single-Cell Classification of Lymphoma Cells

Accurate classification of lymphoma cell subtypes is essential for disease diagnosis and therapeutic decision-making, yet conventional approaches often rely on fluorescence labeling, labor-intensive sample preparation, and specialized instrumentation, limiting their applicability for rapid, label-free single-cell analy...

Lin-Yan Xie, Meng-Fei Wang, Xi-Jiang Luo et al. · 0 citations
Review Open access Sep 2026

Bridging the Resolution Gap in Recurrent Prostate Cancer Imaging: Quantum Dots as PSMA-Targeted Optical Probes

QDs are highlighted as complementary optical probes that may bridge the resolution gap between whole-body imaging and cellular-scale analysis, with particular relevance for preclinical research, ex vivo tissue interrogation, and intraoperative imaging.

Yugmee Gidiya, Jiya Chaudhary, Annafew Biswas et al. · 0 citations
Aug 2026

Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

This work developed and clinically validated the System for Enhanced Evaluation of Tumor Cells (SEE-TC), a deep learning approach for scalable, reproducible phenotyping of individual circulating cells that is the first fully automated AI approach to single-cell segmentation and CTC phenotyping.

M. Bootsma, M. Sharifi, J. Sperger et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.